Table 2 The differences in demographic characteristics and ocular disease spectrum in ophthalmic outpatients during Phases A, B, and C.

From: Changes in the spectrum of ocular disease during the COVID-19 pandemic in late 2022 in the Hubei Province

Demographic characteristics and ocular disease spectrum

Phase A

Phase B

Phase C

p-value

(A versus C)

p-value

(A versus B)

Number of participants

1,968

3,292

5,441

  

Age, median (IQR) (years)

46 (32)

48 (35)

47 (37)

0.4796

0.1614

Male, N (%)

920 (46.75)

1,466 (44.53)

2,496 (45.87)

0.5096

0.1223

Prevalence of ocular diseases, N (%)

 Trauma

127 (6.45)

100 (3.04)

250 (4.59)

0.0018*

< 0.0001*

 Oculoplastics and orbit

327 (16.62)

500 (15.19)

886 (16.28)

0.7490

0.1709

 Strabismus

19 (0.97)

14 (0.43)

35 (0.64)

0.1638

0.0191*

 Refractive errors

213 (10.82)

335 (10.18)

702 (12.90)

0.0164*

0.4560

 Conjunctiva

346 (17.58)

586 (17.80)

1,278 (23.49)

< 0.0001*

0.8521

 Dry eye

134 (6.81)

364 (11.06)

628 (11.54)

< 0.0001*

< 0.0001*

 Cornea

172 (8.74)

212 (6.44)

293 (5.39)

< 0.0001*

0.0021*

  Keratitis

111 (5.64)

70 (2.13)

162 (2.98)

< 0.0001*

< 0.0001*

 Glaucoma

227 (11.53)

357 (10.84)

405 (7.44)

< 0.0001*

0.4411

  AACG

35 (2.30)

8 (0.24)

16 (0.30)

< 0.0001*

< 0.0001*

 Lens

128 (6.50)

376 (11.42)

562 (10.33)

< 0.0001*

< 0.0001*

 Vitreoretinal

249 (12.65)

402 (12.21)

312 (5.73)

< 0.0001*

0.6345

  RVO

41 (2.08)

46 (1.40)

66 (1.21)

0.0078*

0.0732

  RAO

0

0

0

  

  AMN

3 (0.15)

0

0

0.0187*

0.0523

Uveitis

15 (0.76)

30 (0.91)

71 (1.30)

0.0645

0.6441

Neuro-ophthalmology

11 (0.56)

16 (0.49)

19 (0.35)

0.2164

0.6959

  1. IQR, interquartile range; AACG, acute angle closure glaucoma; RVO, retinal vein occlusion; RAO, retinal artery occlusion; and AMN, acute macular neuroretinalpathy. Data are presented as median (IQR) or number (percentage). The p-values are calculated from the Mann–Whitney U test and Fisher’s exact test. *p < 0.05.